Marginal zone lymphoma (MZL) describes a heterogeneous group of indolent lymphoproliferative disorders derived from post–germinal center marginal zone B cells. It is further categorized into subtypes on the basis of predominant area of disease involvement. Extranodal MZL of mucosa-associated lymphoid tissue (known as MALT lymphoma) primarily affects extranodal tissues, whereas nodal and splenic MZL primarily affects the lymph nodes and spleen, respectively. Treatment approach is dependent on MZL subtype.
How should relapsed/refractory MZL be treated? Test your knowledge with this quick quiz.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Christina Poh. Fast Five Quiz: Relapsed/Refractory Marginal Zone Lymphoma - Medscape - Nov 03, 2021.